Clinical Trial

PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 1, 2025 (before its estimated January 7, 2026 completion). Its status may not reflect the trial's current state.
Summary
Pericapsular Nerve Group Block (PENG) is an effective regional anaesthesia modality in providing analgesia following neck of femur fracture. Continuous PENG techniques, using indwelling catheters and infusions of local anaesthetic, facilitate the continuation of analgesia for a number of days following hip fracture surgery. It is unclear from the published literature whether an optimal strategy of local anaesthetic delivery has been characterized. Similar doses of local anaesthetic agents can be administered by either continuous infusion or timed intermittent bolus. It is unclear whether one dosing strategy is superior to the other in the context of hip fracture analgesia. The study aims to evaluate the clinical efficacy of both dosing strategies in patients undergoing hip fracture surgery.
Trial Details
NCT Number NCT07046052
Lead Sponsor University College Cork
Conditions Hip Fracture, Analgesia Post Fracture
Enrollment 150 participants
Start Date 2024-03-28
Primary Completion 2026-01-07 (estimated)
Study Completion 2026-01-07 (estimated)
Updated on ClinicalTrials.gov 2025-07-01